The economic effect of screening orthopedic surgery patients preoperatively for methicillin-resistant Staphylococcus aureus

Infection Control and Hospital Epidemiology

Volumn 31, Issue 11, 2010, Pages 1130-1138

  Lee, Bruce Y ^a,b,c   Wiringa, Ann E ^a,b,c   Bailey, Rachel R ^a,b,c   Goyal, Vishal ^a,b,c   Tsui, Becky ^a,b,c   Lewis, G Jonathan ^a,b,c   Muder, Robert R ^d   Harrison, Lee M ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPUTER SIMULATION; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; HEALTH CARE COST; INFECTION SENSITIVITY; LENGTH OF STAY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; ORTHOPEDIC SURGERY; PREOPERATIVE EVALUATION;

COMPUTER SIMULATION; CROSS INFECTION; HEALTH CARE COSTS; HUMANS; MASS SCREENING; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; ORTHOPEDICS; PREOPERATIVE PERIOD; QUALITY-ADJUSTED LIFE YEARS; STAPHYLOCOCCAL INFECTIONS;

EID: 77957869461     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/656591     Document Type: Article

References (62)

1. Anderson DJ, Sexton DJ, Kanafani ZA, Auten G, Kaye KS. Severe surgical site infection in community hospitals: epidemiology, key procedures, and the changing prevalence of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2007;28(9):1047-1053.
2. Walley G, Orendi J, Bridgman S, Davis B, Ahmed el N, Maffulli N. Methicillin resistant Staphylococcus aureus (MRSA) is not always caught on the orthopaedic ward. Acta Orthop Belg 2009;75(2):245-251.
3. Kato D, Maezawa K, Yonezawa I, et al. Randomized prospective study on prophylactic antibiotics in clean orthopedic surgery in one ward for 1 year. J Orthop Sci 2006;11(1):20-27.
4. Khan OA, Weston VC, Scammell BE. Methicillin-resistant Staphylococcus aureus incidence and outcome in patients with neck of femur fractures. J Hosp Infect 2002;51(3):185-188.
5. Peacock JE Jr, Marsik FJ, Wenzel RP. Methicillin-resistant Staphylococcus aureus: introduction and spread within a hospital. Ann Intern Med 1980;93(4):526-532.
6. Wilcox MH, Hall J, Pike H, et al. Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections. J Hosp Infect 2003;54(3):196-201.
7. Trautmann M, Stecher J, Hemmer W, Luz K, Panknin HT. Intranasal mupirocin prophylaxis in elective surgery: a review of published studies. Chemotherapy 2008;54(1):9-16.
8. Hacek DM, Paule SM, Thomson RB Jr, Robicsek A, Peterson LR. Implementation of a universal admission surveillance and decolonization program for methicillin-resistant Staphylococcus aureus (MRSA) reduces the number of MRSA and total number of S. aureus isolates reported by the clinical laboratory. J Clin Microbiol 2009;47(11):3749-3752.
9. Davis KA, Stewart JJ, Crouch HK, Florez CE, Hospenthal DR. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 2004;39(6):776-782.
10. Gorwitz RJ, Kruszon-Moran D, McAllister SK, et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 2008;197(9):1226-1234.
11. Perl TM. Prevention of Staphylococcus aureus infections among surgical patients: beyond traditional perioperative prophylaxis. Surgery 2003;134(suppl 5):S10-S17.
12. Kluytmans JA, Wertheim HF. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Infection 2005;33(1):3-8.
13. Harbarth S, Dharan S, Liassine N, Herrault P, Auckenthaler R, Pittet D. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1999;43(6):1412-1416.
14. Robicsek A, Beaumont JL, Thomson RB Jr, Govindarajan G, Peterson LR. Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk. Infect Control Hosp Epidemiol 2009;30(7):623-632.
15. Garrouste-Orgeas M, Timsit JF, Kallel H, et al. Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: morbidity, mortality, and glycopeptide use. Infect Control Hosp Epidemiol 2001;22(11):687-692.
16. Sankar B, Hopgood P, Bell KM. The role of MRSA screening in joint-replacement surgery. Int Orthop 2005;29(3):160-163.
17. Beigi RH, Bunge K, Song Y, Lee BY. Epidemiologic and economic effect of methicillin-resistant Staphylococcus aureus in obstetrics. Obstet Gynecol 2009;113(5):983-991.
18. Lee BY, Tsui BY, Bailey RR, et al. Should vascular surgery patients be screened preoperatively for methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol 2009;30:1158-1165.
19. Hacek DM, Robb WJ, Paule SM, Kudrna JC, Stamos VP, Peterson LR. Staphylococcus aureus nasal decolonization in joint replacement surgery reduces infection. Clin Orthop Relat Res 2008;466(6):1349-1355.
20. Bounthavong M, Hsu DI, Okamoto MP. Cost-effectiveness analysis of linezolid vs. vancomycin in treating methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections using a decision analytic model. Int J Clin Pract 2009;63(3):376-386.
21. CPT Code/Relative Value Search. American Medical Association Web site. https://catalog.ama-assn.org/Catalog/cpt/cpt-search.jsp. Accessed April 17, 2009.
22. Levit K, Stranges E, Ryan K, Elixhauser A. HCUP Facts and Figures, 2006: Statistics on Hospital-based Care in the United States. Rockville, MD: Agency for Healthcare Research and Quality, 2008.
23. Gold MR, Franks P, McCoy KI, Fryback DG. Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Med Care 1998;36(6):778-792.
24. Tengs TO, Wallace A. One thousand health-related quality-of-life estimates. Med Care 2000;38(6):583-637.
25. Sackett DL, Torrance GW. The utility of different health states as perceived by the general public. J Chronic Dis 1978;31(11):697-704.
26. Selai C, Rosser R. Eliciting EuroQol descriptive data and utility scale values from inpatients: a feasibility study. Pharmacoeconomics 1995;8(2):147-158.
27. Reyes J, Hidalgo M, Diaz L, et al. Characterization of macrolide resistance in gram-positive cocci from Colombian hospitals: a countrywide surveillance. Int J Infect Dis 2007;11(4):329-336.
28. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 2001;344(1):11-16. (Pubitemid 32064839)
29. Ellis MW, Hospenthal DR, Dooley DP, Gray PJ, Murray CK. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 2004;39(7):971-979.
30. Pujol M, Pena C, Pallares R. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 1996;100(5):509-516.
31. Huang SS, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 2003;36(3):281-285.
32. Corbella X, Dominguez MA, Pujol M. Staphylococcus aureus nasal carriage as a marker for subsequent staphylococcal infections in intensive care unit patients. Eur J Clin Microbiol Infect Dis 1997;16(5):351-357.
33. Lee YL, Cesario T, Gupta G. Surveillance of colonization and infection with Staphylococcus aureus susceptible or resistant to methicillin in a community skilled-nursing facility. Am J Infect Control 1997;25(4):312-321.
34. Nather A, Bee CS, Huak CY. Epidemiology of diabetic foot problems and predictive factors for limb loss. J Diabetes Complications 2008;22(2):77-82.
35. Roche SJ, Fitzgerald D, O'Rourke A, McCabe JP. Methicillin-resistant Staphylococcus aureus in an Irish orthopaedic centre: a five-year analysis. J Bone Joint Surg Br 2006;88(6):807-811.
36. Kilgus DJ, Howe DJ, Strang A. Results of periprosthetic hip and knee infections caused by resistant bacteria. Clin Orthop Relat Res 2002;404:116-124.
37. Tai CC, Nirvani AA, Holmes A, Hughes SP. Methicillin-resistant Staphylococcus aureus in orthopaedic surgery. Int Orthop 2004;28(1):32-35.
38. Sankar B, Hopgood P, Bell KM. The role of MRSA screening in joint-replacement surgery. Int Orthop 2005;29:160-163.
39. Wenisch C, Laferl H, Szell M, et al. A holistic approach to MRSA eradication in critically ill patients with MRSA pneumonia. Infection 2006;34(3):148-154.
40. Drinka P, Faulks JT, Gauerke C, Goodman B, Stemper M, Reed K. Adverse events associated with methicillin-resistant Staphylococcus aureus in a nursing home. Arch Intern Med 2001;161(19):2371-2377.
41. DeRyke CA, Lodise TP Jr, Rybak MJ, McKinnon PS. Epidemiology, treatment and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia. Chest 2005;128(3):1414-1422.
42. Fleisch F, Zbinden R, Vanoli C, Ruef C. Epidemic spread of a single clone of methicillin-resistant Staphylococcus aureus among injection drug users in Zurich, Switzerland. Clin Infect Dis 2001;32(4):581-586.
43. Athanassa Z, Siempos II, Falagas ME. Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systemic review. Eur Respir J 2008;31(3):625-632.
44. Wunderink RG, Rello J, Cammarata SK, Croos-Dabrera RV, Kollef MH. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 2003;124(5):1789-1797.
45. Jeffres MN, Isakow W, Doherty JA, et al. Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia. Chest 2006;130(4):947-955.
46. Hageman JC, Uyeki TM, Francis JS, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis 2006;12(6):894-899.
47. Kollef KE, Reichley RM, Micek ST, Kollef MH. The modified APACHE II score outperforms Curb65 pneumonia severity score as a predictor of 30-day mortality in patients with methicillin-resistant Staphylococcus aureus pneumonia. Chest 2008;133(2):363-369.
48. Wilmoth J, Shkolnikov V. The human mortality database. The human mortality database Web site. http://www.mortality.org. Accessed April 12, 2009.
49. Gold M, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press, 1996.
50. Sloan F. Valuing Health Care: Costs, Benefits, and Effectiveness of Pharmaceuticals and Medical Technologies. New York, NY: Cambridge University Press, 1995.
51. Braithwaite RS, Meltzer DO, King JT Jr, Leslie D, Roberts MS. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule? Med Care 2008;46(4):349-356.
52. Rabinovich M, Greenberg D, Shemer J. Threshold values for cost-effectiveness ratio and public funding of medical technologies [in Hebrew]. Harefuah 2007;146(6):453-458, 500.
53. Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 1992;146(4):473-481.
54. Shorr AF, Tabak YP, Killian AD, Gupta V, Liu LZ, Kollef MH. Healthcare-associated bloodstream infection: a distinct entity? Insights from a large U.S. database. Crit Care Med 2006;34(10):2588-2595.
55. Graves N, Halton K, Lairson D. Economics and preventing hospital-acquired infection: broadening the perspective. Infect Control Hosp Epidemiol 2007;28(2):178-184.
56. Graves N. Economics and preventing hospital-acquired infection. Emerg Infect Dis 2004;10(4):561-566.
57. Clinical laboratory fee schedule. Centers for Medicare and Medicaid Services Web site. http://www.cms.gov/ClinicalLabFeeSched/02-clinlab. asp#TopOfPage. Published 2010. Accessed April 2, 2010.
58. McConeghy KW, Mikolich DJ, LaPlante KL. Agents for the decolonization of methicillin-resistant Staphylococcus aureus. Pharmacotherapy 2009;29(3):263-280.
59. Red Book 2009. Montvale, NJ: Thompson Healthcare, 2009.
60. Cookson BD. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J Antimicrob Chemother 1998;41(1):11-18.
61. Ammerlaan HS, Kluytmans JA, Wertheim HF, Nouwen JL, Bonten MJ. Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. Clin Infect Dis 2009;48(7):922-930.
62. Lee BY, Bailey RR, Smith KJ, et al. Universal methicillin-resistant Staphylococcus aureus (MRSA) surveillance for adults at hospital admission: an economic model and analysis. Infect Control Hosp Epidemiol 2010;31:598-606.